Data di Pubblicazione:
2021
Abstract:
Pathophysiology and effects of endogenous glucocorticoid (GC) excess on skeletal endpoints as well as awareness and management of bone fragility are reviewed. Cushing's syndrome (CS) increase the risk of fracture affecting prevalently bone quality. Bone antiresorptive agents (SERMs, bisphosphonates and denosumab) as well as teriparatide increase bone mineral density and in some instances reduce fracture risk. Awareness and management of bone health in CS can be improved.(c) 2021 Elsevier Ltd. All rights reserved.
Tipologia CRIS:
1.1.3. Articolo in Rivista - Editorial, Comment, Reply
Keywords:
adrenal incidentaloma; bone mineral density; bone quality; cushing disease; fractures; glucocorticoids
Elenco autori:
Frara, Stefano; Allora, Agnese; di Filippo, Luigi; Formenti, Anna Maria; Loli, Paola; Polizzi, Elisabetta; Tradati, Daniele; Ulivieri, Fabio Massimo; Giustina, Andrea
Link alla scheda completa:
Pubblicato in: